Patent · US Active

Assessment of hemodynamic function in arrhythmia patients

US10638940B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2016
Grant dateMay 5, 2020
Priority date
Expiry dateMay 24, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H30/40
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Electrocardiogram (ECG)-gated cardiac magnetic resonance imaging (MRI) alone may be unable to capture the hemodynamics associated with arrhythmic events. As a result, values such as ejection fraction are acquisition dependent. The desired RR-duration determines the arrhythmia rejection. By combining real-time volume measurements with ECG recordings, beat morphologies can be categorized and a more comprehensive evaluation of ventricular function during arrhythmia can be provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.